-Livemint.com Farm economist and NITI Aayog member Ramesh Chand on the urgency of agricultural market reforms to meet the target of doubling farm incomes by 2022 New Delhi: Apart from staging protests in Delhi, farmers must make themselves heard in state capitals as well to resolve issues outside the central government’s control, farm economist and NITI Aayog member Ramesh Chand said. In an interview, he spoke of the urgency of agricultural market...

-The Indian Express Modi government’s decision to hike Import Duty on edible oils has come too little, too late for soyabean farmers Latur: Arun Kulkarni planted soyabean on 10 out of his 14-acre holding in the recent kharif season and harvested 65 quintals of the crop towards September-end. But unlike most of his neighbours, this farmer from Tandulja village in Latur — Maharashtra’s largest soyabean-growing district and the country’s No. 2...

-Livemint.com BJP-led central government has raised import duties on a range of edible oils, ahead of the crucial Gujarat assembly elections New Delhi: Ahead of the crucial Gujarat assembly elections, the centre last week raised import duties on a range of edible oils, in a bid to support growers who are bearing losses due to plunging domestic prices. On 17 November, India, the largest importer of edible oils globally, raised import duties on...

-Down to Earth The development will directly benefit chickpea farmers, who are likely to get higher price for chickpea crops this season There is some good news this Rabi season for farmers who grow chickpea (also known as gram, chana). The Central government has imposed 50 per cent duty on the import of peas, in a bid to check cheaper import from Canada. The import of cheap peas directly affects chickpea farmers, as...

-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope...